<div id="readability-page-1"><div><p>As global markets grapple with rising inflation and geopolitical uncertainties, Asian equities present intriguing opportunities for investors seeking value. In this environment, identifying stocks that are trading significantly below their intrinsic value can be particularly appealing, offering potential for growth when market conditions stabilize.</p><h3>Top 10 Undervalued Stocks Based On Cash Flows In Asia</h3><div><table><tbody><tr><td><strong>Name</strong></td><td><strong>Current Price</strong></td><td><strong>Fair Value (Est)</strong></td><td><strong>Discount (Est)</strong></td></tr><tr><td>Strike Group (TSE:6196)</td><td>¥1212.00</td><td>¥2378.82</td><td>49.1%</td></tr><tr><td>Plus Alpha ConsultingLtd (TSE:4071)</td><td>¥2394.00</td><td>¥4703.99</td><td>49.1%</td></tr><tr><td>NTT DC REIT (SGX:NTDU)</td><td>US$0.98</td><td>US$1.94</td><td>49.5%</td></tr><tr><td>Moshi Moshi Retail Corporation (SET:MOSHI)</td><td>THB36.25</td><td>THB69.86</td><td>48.1%</td></tr><tr><td>LianChuang Electronic TechnologyLtd (SZSE:002036)</td><td>CN¥8.83</td><td>CN¥17.24</td><td>48.8%</td></tr><tr><td>Intco Medical Technology (SZSE:300677)</td><td>CN¥50.44</td><td>CN¥100.72</td><td>49.9%</td></tr><tr><td>Cybozu (TSE:4776)</td><td>¥2449.00</td><td>¥4865.51</td><td>49.7%</td></tr><tr><td>Beijing Luzhu Biotechnology (SEHK:2480)</td><td>HK$19.70</td><td>HK$39.26</td><td>49.8%</td></tr><tr><td>BEAUTY GARAGE (TSE:3180)</td><td>¥1455.00</td><td>¥2824.07</td><td>48.5%</td></tr><tr><td>APR (KOSE:A278470)</td><td>₩397500.00</td><td>₩782216.21</td><td>49.2%</td></tr></tbody></table></div><p>Click here to see the full list of 195 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.</p><p>Underneath we present a selection of stocks filtered out by our screen.</p><h2>Plus Alpha ConsultingLtd (TSE:4071)</h2><p><strong>Overview:</strong> Plus Alpha Consulting Co., Ltd. offers marketing and HR solutions in Japan, with a market cap of ¥101.48 billion.</p><p><strong>Operations:</strong> Plus Alpha Consulting Co., Ltd. generates revenue through its marketing and human resources solutions in Japan.</p><p><strong>Estimated Discount To Fair Value:</strong> 49.1%</p><p>Plus Alpha Consulting Ltd. is trading at ¥2,394, significantly below its estimated future cash flow value of ¥4,703.99, indicating it may be undervalued based on cash flows. Despite a moderate revenue growth forecast of 12.6% annually—higher than the Japanese market's average—the company's earnings are expected to grow at 17.5% per year, outpacing the market's 8.8%. Recent board discussions about increasing dividend payout ratios could enhance shareholder returns further.</p><ul><li>The growth report we've compiled suggests that Plus Alpha ConsultingLtd's future prospects could be on the up.</li><li>Get an in-depth perspective on Plus Alpha ConsultingLtd's balance sheet by reading our health report here.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a6c28592-bcb7-4305-8f5b-f6b1e621ab4b/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a6c28592-bcb7-4305-8f5b-f6b1e621ab4b/chart/dcf/query-dGhlbWU9bGlnaHQ"/><figcaption>TSE:4071 Discounted Cash Flow as at May 2026</figcaption></figure><h2>Medley (TSE:4480)</h2><p><strong>Overview:</strong> Medley, Inc. operates platforms for recruitment and medical businesses in Japan and the United States, with a market cap of ¥67.96 billion.</p><p><strong>Operations:</strong> The company's revenue segments include recruitment platforms generating ¥12.34 billion and medical business platforms contributing ¥8.56 billion.</p><p><strong>Estimated Discount To Fair Value:</strong> 33.7%</p><p>Medley, Inc. is trading at ¥2,260, below its estimated future cash flow value of ¥3,408.64, reflecting potential undervaluation based on cash flows. Earnings are projected to grow significantly at 29.7% annually over the next three years, surpassing the Japanese market's average growth rate of 8.8%. However, profit margins have decreased from 7.2% to 2.5%. Recent strategic moves include a share buyback and plans to acquire Recruit Medical Career Co., Ltd.'s business operations as a subsidiary.</p><ul><li>Our growth report here indicates Medley may be poised for an improving outlook.</li><li>Click here to discover the nuances of Medley with our detailed financial health report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/54ac06f7-e3c9-443c-baec-dd705f917a22/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/54ac06f7-e3c9-443c-baec-dd705f917a22/chart/dcf/query-dGhlbWU9bGlnaHQ"/><figcaption>TSE:4480 Discounted Cash Flow as at May 2026</figcaption></figure><h2>Socionext (TSE:6526)</h2><p><strong>Overview:</strong> Socionext Inc. is a global company that designs, develops, manufactures, and sells system-on-chip (SoC) and related solutions/services, with a market cap of ¥403.49 billion.</p><p><strong>Operations:</strong> The company's revenue segment primarily consists of SoC developed with The Solution SoC, amounting to ¥200.83 million.</p><p><strong>Estimated Discount To Fair Value:</strong> 38.4%</p><p>Socionext Inc. is trading at ¥2,302, significantly below its estimated future cash flow value of ¥3,734.2, suggesting undervaluation based on cash flows. Earnings are expected to grow substantially at 29% annually over the next three years, outpacing the Japanese market's average growth. However, profit margins have declined from 10.4% to 4.3%, and dividends remain inadequately covered by earnings or free cash flows despite recent dividend affirmations and guidance updates for fiscal year 2027.</p><ul><li>Our expertly prepared growth report on Socionext implies its future financial outlook may be stronger than recent results.</li><li>Click to explore a detailed breakdown of our findings in Socionext's balance sheet health report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7e3f0549-c053-4237-ab72-0dc41dca9664/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7e3f0549-c053-4237-ab72-0dc41dca9664/chart/dcf/query-dGhlbWU9bGlnaHQ"/><figcaption>TSE:6526 Discounted Cash Flow as at May 2026</figcaption></figure><h2>Key Takeaways</h2><ul><li>Reveal the 195 hidden gems among our Undervalued Asian Stocks Based On Cash Flows screener with a single click here.</li><li>Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.</li><li>Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.</li></ul><h2>Interested In Other Possibilities?</h2><ul><li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li><li>Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li><li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.      It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation.</strong> We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p><div><h3><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>• Connect an unlimited number of Portfolios and see your total in one currency<br/>• Be alerted to new Warning Signs or Risks via email or mobile<br/>• Track the Fair Value of your stocks<br/></p><p>Try a Demo Portfolio for Free</p></div></div></div>

4071

4480

<p>Asian equities are currently presenting investment opportunities, with stocks like Plus Alpha Consulting, Medley, and Socionext estimated to be undervalued by 33.7% to 49.1% compared to their intrinsic values. These companies show potential for growth, with earnings expected to outpace market averages despite some challenges. Investors are encouraged to explore these undervalued stocks as market conditions stabilize.</p>

3 Asian Stocks Estimated To Be 33.7% To 49.1% Below Intrinsic Value